# Cystoscopic Evaluation Predicting pT0 Urothelial Carcinoma of the Bladder

> **NCT02968732** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Fox Chase Cancer Center** · enrollment: 65 (actual)

## Conditions studied

- Urothelial Carcinoma

## Interventions

- **PROCEDURE:** Radical Cystectomy

## Key facts

- **NCT ID:** NCT02968732
- **Lead sponsor:** Fox Chase Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2016-11-11
- **Primary completion:** 2019-08-19
- **Final completion:** 2027-04-01
- **Target enrollment:** 65 (ACTUAL)
- **Last updated:** 2025-07-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02968732

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02968732, "Cystoscopic Evaluation Predicting pT0 Urothelial Carcinoma of the Bladder". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT02968732. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*